A Single-Dose, Single Period, Phase II Pharmacokinetic Study To Examine Testagen TDS-Testosterone For Its Potential To Be Inadvertently Transferred By Skin Contact After Dosing In Healthy Adult Subjects
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs Testosterone (Primary) ; Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Acronyms TRANSFERENCE
- Sponsors Transdermal Delivery Solutions Corp
- 09 Sep 2019 Planned End Date changed from 1 Mar 2019 to 1 Mar 2021.
- 09 Sep 2019 Planned primary completion date changed from 1 Oct 2018 to 1 Oct 2020.
- 31 Aug 2018 Biomarkers information updated